We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Varian Opens New Manufacturing Facility in Beijing

By HospiMedica staff writers
Posted on 29 Aug 2007
Varian Medical Systems (Palo Alto, CA, USA), a leading supplier of radiotherapy products for treating cancer, celebrated the grand opening and inauguration of a new manufacturing plant in China on July 28, 2007. More...


The new plant, situated in the Beijing Economic Technical Development Area (BDA), will produce linear accelerators for the treatment of cancer patients in China. The project, which took 14 months to complete, received significant support from the municipal government of Beijing, as well as the BDA.

With this grand opening we are celebrating a great opportunity to offer more cancer treatment centers products and technology for advanced radiotherapy, said Varian president and CEO Tim Guertin. Mr. Guertin hosted the celebration together with Dow Wilson, president of Varian's Oncology Systems business and Wang Xiao Yun, managing director of Varian Medical Systems Beijing Co., Ltd. Other guests included officials from Beijing's municipal government and the Beijing Economic-Technological Development area, the chairman of the American Chamber of Commerce, and nearly 100 customers and other partners from Beijing and other parts of the country.

Varian will initially use the Beijing manufacturing facility and team to produce the Clinac CX, a medical linear accelerator designed to meet the specifications of cancer treatment centers in China. Furthermore, the company is planning to add an X-ray service facility incorporating X-ray tube assembly in support of its expanding original equipment manufacturer (OEM) and service business. Varian is an independent supplier of X-ray tubes for advanced diagnostic applications including compute tomography (CT) scanning, radiography, and mammography.

The new factory adds capacity complementary to Varian's main manufacturing site in Palo Alto, and positions the company to meet increasing global demand for its medical linear accelerators. It consists of an office building, as well as an advanced manufacturing facility built in strict accordance with the company's global design, construction, and quality standards. It is a multifunctional facility housing manufacturing, marketing, sales, service, sourcing, engineering, and customer education and training.


Related Links:
Varian Medical Systems

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Ultrasound System
FUTUS LE
Blood Bank Refrigerator
MBR-705GR-PE
Infant Incubator
OKM 801
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.